Moldova-EU Push: Romania’s ambassador Cristian-Leon Țurcanu says Moldova’s EU accession is “priority number 0,” pointing to concrete Bucharest–Chisinau projects in energy, infrastructure, education and research, while stressing reunification depends on citizens’ will. Gene Therapy Watch: AskBio presented baseline results from the Phase 2 GenePHIT trial of umiposgene parvec (AB-1002) for non-ischemic heart failure at the ESC Congress, with initial efficacy and safety expected in 2027. Cybersecurity: Researchers warn of HOOKEDGE malware in a BlueDelta-linked espionage campaign targeting defense, government and diplomatic orgs in Romania and beyond, using macro Word lures and lightweight Windows backdoors. Nuclear & Heat Resilience: A new report highlights how Europe’s extreme heat and low river levels are forcing nuclear plants to cut output or shut down, raising questions about reliability. Renewables Grid Milestone: Eurowind secured technical connection approvals for 2.3GW of Romanian wind/solar/storage projects, but says real capacity depends on grid reinforcement and permits after 2030. Defense Funding: Romania received €2.5bn SAFE pre-financing (15% of its allocation) to accelerate procurement and expand domestic production for radars, helicopters, air defense and more. Innovation Call: NASA Space Apps Challenge returns to Romania on Nov 14–15 with Bucharest and Cluj-Napoca events, using open data for Earth and space exploration solutions. Local Tech Business: AROBS reported 121% higher net profit in H1 2026, driven by software services growth and integration of acquired capabilities.